Growth Metrics

Idexx Laboratories (IDXX) Cash from Investing Activities (2016 - 2026)

Idexx Laboratories has reported Cash from Investing Activities over the past 17 years, most recently at -$28.1 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 29.4% year-over-year to -$28.1 million; the TTM value through Dec 2025 reached -$136.2 million, up 34.2%, while the annual FY2025 figure was -$136.2 million, 34.2% up from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$28.1 million at Idexx Laboratories, up from -$44.9 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at -$24.6 million in Q1 2021 and troughed at -$174.7 million in Q2 2021.
  • A 5-year average of -$47.8 million and a median of -$39.7 million in 2023 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: tumbled 611.28% in 2021 and later soared 72.31% in 2025.
  • Year by year, Cash from Investing Activities stood at -$44.0 million in 2021, then fell by 11.78% to -$49.2 million in 2022, then skyrocketed by 38.18% to -$30.4 million in 2023, then crashed by 30.91% to -$39.8 million in 2024, then increased by 29.4% to -$28.1 million in 2025.
  • Business Quant data shows Cash from Investing Activities for IDXX at -$28.1 million in Q4 2025, -$44.9 million in Q3 2025, and -$33.6 million in Q2 2025.